KPL — Kwality Pharmaceuticals Share Price
0.000.00%
Last trade - 00:00- IN₹22.18bn
- IN₹23.43bn
- IN₹5.03bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.69 | ||
| Price to Tang. Book | 6.81 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.41 | ||
| EV to EBITDA | 19.95 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 26.62% | ||
| Return on Equity | 22.61% | ||
| Operating Margin | 19.4% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 4,561.85 | 2,510.3 | 3,071.72 | 3,701.97 | 5,030.83 | n/a | n/a | 13.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +692.23 | -73.5 | -8.2 | +36.45 | +70.66 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.
Directors
- Aditya Arora CFO (22)
- Gurpreet Kaur CCO
- Ramesh Arora MDR (61)
- Ajay Arora EDR (49)
- Anju Arora EDR (54)
- Geeta Arora EDR (45)
- Shankar Dayal OTH (31)
- Neeraj Lakhanpal OTH (31)
- Lakhvinder Singh OTH (31)
- Karunakar Tiwari OTH (45)
- Kartik Kapur NID (26)
- Ravi Singh NID (43)
- Pankaj Takkar NID (38)
- Kiran Verma NID (43)
- Last Annual
- March 31st, 2026
- Last Interim
- March 31st, 2026
- Incorporated
- May 4th, 1983
- Public Since
- July 18th, 2016
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 10,376,198
- Address
- Vill.Nag Kalan,Majitha Road, AMRITSAR, 143601
- Web
- https://www.kwalitypharma.com/
- Phone
- +91 1832774321
- Auditors
- Vijay Mehra & Co.
Upcoming Events for KPL
Similar to KPL
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Kwality Pharmaceuticals share price?
As of Today at 12:41 UTC, shares in Kwality Pharmaceuticals are trading at IN₹2,137.40. This share price information is delayed by 15 minutes.
How has the Kwality Pharmaceuticals share price performed this year?
Shares in Kwality Pharmaceuticals last closed at IN₹2,137.40 and the price had moved by over the past 365 days. In terms of relative price strength the Kwality Pharmaceuticals share price has matched the S&P BSE 100 Index by over the past year.
What are the analyst and broker recommendations for Kwality Pharmaceuticals?
There is no consensus recommendation for this security.
Find out moreWhat is the Kwality Pharmaceuticals dividend yield?
Kwality Pharmaceuticals does not currently pay a dividend.
Does Kwality Pharmaceuticals pay a dividend?
Kwality Pharmaceuticals does not currently pay a dividend.
When does Kwality Pharmaceuticals next pay dividends?
Kwality Pharmaceuticals does not currently pay a dividend.
How do I buy Kwality Pharmaceuticals shares?
To buy shares in Kwality Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kwality Pharmaceuticals?
As of the previous close price of IN₹2,137.40, shares in Kwality Pharmaceuticals had a market capitalisation of IN₹22.18bn.
Where are Kwality Pharmaceuticals shares listed?
Here are the trading details for Kwality Pharmaceuticals:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: KPL
What kind of share is Kwality Pharmaceuticals?
Based on an overall assessment of its quality, value and momentum Kwality Pharmaceuticals is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kwality Pharmaceuticals share price forecast for 2026?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Kwality Pharmaceuticals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kwality Pharmaceuticals. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹2,137.40, shares in Kwality Pharmaceuticals were trading +23.11% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kwality Pharmaceuticals PE Ratio?
The Kwality Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹2,137.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kwality Pharmaceuticals?
Kwality Pharmaceuticals' management team is headed by:
- Aditya Arora - CFO
- Gurpreet Kaur - CCO
- Ramesh Arora - MDR
- Ajay Arora - EDR
- Anju Arora - EDR
- Geeta Arora - EDR
- Shankar Dayal - OTH
- Neeraj Lakhanpal - OTH
- Lakhvinder Singh - OTH
- Karunakar Tiwari - OTH
- Kartik Kapur - NID
- Ravi Singh - NID
- Pankaj Takkar - NID
- Kiran Verma - NID